Prognostic performance of inflammation-based prognostic indices in locally advanced non-small-lung cancer treated with endostar and concurrent chemoradiotherapy

about

Effect of silencing TEM8 gene on proliferation, apoptosis, migration and invasion of XWLC‑05 lung cancer cells.

P2860

Q50111461-8111C8DE-3758-46A2-A74E-623C98EA64E5

P2860

Prognostic performance of inflammation-based prognostic indices in locally advanced non-small-lung cancer treated with endostar and concurrent chemoradiotherapy

Item

http://www.wikidata.org/entity/Q36824972

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Prognostic performance of infl ...... d concurrent chemoradiotherapy

@en

type

Item

label

Prognostic performance of infl ...... d concurrent chemoradiotherapy

@en

prefLabel

Prognostic performance of infl ...... d concurrent chemoradiotherapy

@en

P1476

Prognostic performance of infl ...... d concurrent chemoradiotherapy

@en

P2093

Fang Peng

http://www.w3.org/2001/XMLSchema#string

Honglian Ma

http://www.w3.org/2001/XMLSchema#string

Huarong Tang

http://www.w3.org/2001/XMLSchema#string

Jin Wang

http://www.w3.org/2001/XMLSchema#string

Ming Chen

http://www.w3.org/2001/XMLSchema#string

Xiao Hu

http://www.w3.org/2001/XMLSchema#string

Yong Bao

http://www.w3.org/2001/XMLSchema#string

Yujin Xu

http://www.w3.org/2001/XMLSchema#string

P2860

Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche

Cancer statistics, 2015

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

Preoperative Neutrophil-to-Lymphocyte Ratio as a New Prognostic Marker in Hepatocellular Carcinoma after Curative Resection.

Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410.

American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003.

Tumor inflammatory angiogenesis and its chemoprevention.

The association of pre-treatment neutrophil to lymphocyte ratio with response rate, progression free survival and overall survival of patients treated with sunitinib for metastatic renal cell carcinoma

Systematic review and meta-analysis of Endostar (rh-endostatin) combined with chemotherapy versus chemotherapy alone for treating advanced non-small cell lung cancer.

P304

801-806

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/MCO.2016.796

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

296626283

http://www.w3.org/2001/XMLSchema#string

P698

27123283

http://www.w3.org/2001/XMLSchema#string

P921

chemoradiotherapy

P932

4840764

http://www.w3.org/2001/XMLSchema#string

Prognostic performance of inflammation-based prognostic indices in locally advanced non-small-lung cancer treated with endostar and concurrent chemoradiotherapy

about

P2860

P2860

Prognostic performance of inflammation-based prognostic indices in locally advanced non-small-lung cancer treated with endostar and concurrent chemoradiotherapy

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932